10-Q: Northern Technologies International Corporation Reports Q3 2024 Results: Mixed Performance Amidst Inflationary Pressures

Northern Technologies International Corporation's Q3 2024 results show a slight decrease in net sales but an increase in net income, with mixed performance across its ZERUST and Natur-Tec segments.

Summary

• Northern Technologies International Corporation (NTIC) reported its financial results for the third quarter of fiscal year 2024, ending May 31, 2024.
• Net sales decreased slightly by 1.4% to $20.69 million compared to $20.97 million in the same quarter of the previous year, primarily due to decreased demand for ZERUST products.
• However, net sales for the nine months ended May 31, 2024, increased by 4.3% to $61.71 million compared to $59.19 million in the same period of the previous year, driven by increased sales of Natur-Tec products.
• Cost of goods sold decreased to 61.8% of net sales for both the three and nine-month periods, compared to 63.9% and 65.8% respectively in the prior year, due to lower raw material prices and insourcing of production.
• Operating expenses increased by 7.1% and 7.3% for the three and nine-month periods, respectively, primarily due to increased personnel expenses.
• Net income attributable to NTIC was $0.10 per diluted share for the quarter, compared to $0.11 in the prior year, and $0.36 per diluted share for the nine-month period, compared to $0.20 in the prior year.
• The company declared cash dividends of $0.07 per share for each of the three months ended May 31, 2024, totaling $0.21 per share for the nine-month period.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company shows growth in the Natur-Tec segment and improved cost of goods sold, the decrease in overall net sales and net income for the quarter, along with increased operating expenses and a material weakness in internal controls, temper the positive aspects. The company's reliance on joint ventures and exposure to global economic factors also add uncertainty.

Positives

• The company experienced a decrease in cost of goods sold as a percentage of net sales, indicating improved efficiency or lower input costs.
• Natur-Tec sales increased by 20.1% and 22.5% for the three and nine-month periods, respectively, showing strong growth in this segment.
• Net income attributable to NTIC increased significantly for the nine-month period, reaching $3,573,294, compared to $1,973,329 in the prior year.
• The company remains in compliance with all debt covenants under its credit agreement.

Negatives

• Consolidated net sales decreased by 1.4% in Q3 2024 compared to Q3 2023, primarily due to decreased demand for ZERUST products.
• Operating expenses increased by 7.1% and 7.3% for the three and nine-month periods, respectively, due to higher personnel costs.
• Net income attributable to NTIC decreased for the three months ended May 31, 2024, compared to the same period in 2023.
• The company experienced a decrease in net sales at its joint venture in Germany.

Risks

• The company is exposed to fluctuations in foreign currency exchange rates, which could impact reported net income.
• Commodity price changes, particularly in plastic and bioplastic resins, could affect the cost of goods sold.
• The company's sales of ZERUST products to the oil and gas industry are subject to volatility.
• The company is implementing a new ERP system, which could cause disruptions to its business.
• The company has a material weakness in its internal control over financial reporting related to the recognition of income from employee retention credits.

Future Outlook

NTIC expects to continue to invest in Zerust India, NTIC China, NTI Europe, its joint ventures, research and development, marketing efforts, and its Natur-Tec bio-plastics business. The company also anticipates that its earnings will continue to be affected by inflation and supply chain disruptions. NTIC expects its quarterly net income to remain subject to volatility due to the financial performance of its subsidiaries and joint ventures, sales of ZERUST products to the oil and gas industry, and sales of its Natur-Tec bioplastics products.

Management Comments

• NTIC's management believes that a combination of its existing cash and cash equivalents, available for sale securities, forecasted cash flows from future operations, anticipated distributions of earnings, anticipated fees to NTIC for services provided to its joint ventures, and funds available through existing or anticipated financing arrangements will be adequate to fund its existing operations, investments in new or existing joint ventures or subsidiaries, capital expenditures, debt repayments, cash dividends, and any stock repurchases for at least the next 12 months.
• Management is taking steps to remediate the material weakness in its internal control over financial reporting relating to the proper accounting treatment of the ERCs.

Industry Context

The report indicates that NTIC is navigating a complex global market with fluctuating demand for its products, particularly in the ZERUST segment. The company's expansion into the oil and gas industry and its focus on bio-based plastics align with broader industry trends towards sustainability and diversification. The company's performance is also affected by global economic conditions, including inflation and supply chain disruptions, which are impacting many businesses across various sectors.

Comparison to Industry Standards

• NTIC's gross margin of 38.2% for the quarter is comparable to other specialty chemical and materials companies, but the company's performance is heavily influenced by its joint venture structure and international operations.
• The company's operating expense ratio of 43.4% is higher than some of its peers, reflecting its investments in sales and marketing, as well as research and development.
• NTIC's net income margin of 4.7% for the quarter is lower than some of its competitors, but the company's focus on long-term growth and strategic investments may justify this lower profitability in the short term.
• Compared to companies like Cortec Corporation and Daubert Cromwell, which also specialize in corrosion prevention, NTIC's performance is similar in terms of revenue growth, but NTIC's reliance on joint ventures and international operations makes direct comparisons challenging.
• In the bioplastics sector, NTIC's Natur-Tec segment is competing with companies like Novamont and NatureWorks, and the company's growth in this segment is a positive sign of its ability to capture market share in this growing industry.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net sales and net income for the quarter, but the increase in net income for the nine-month period and the continued dividend payments are positive.
• Employees may be affected by the increased personnel expenses and the ongoing efforts to remediate the material weakness in internal controls.
• Customers may experience some disruptions due to the implementation of the new ERP system.
• Suppliers may be affected by the company's efforts to manage its supply chain and raw material costs.
• Creditors may be reassured by the company's compliance with debt covenants, but the material weakness in internal controls may raise some concerns.

Next Steps

• The company expects to continue to invest in its various business segments and joint ventures.
• NTIC plans to continue to monitor and address the material weakness in its internal control over financial reporting.
• The company will continue to evaluate and manage its exposure to market risks, including foreign currency exchange rates and commodity prices.
• NTIC will continue to assess the impact of global economic conditions and supply chain disruptions on its business.

Key Dates

Keywords

ZERUST, Natur-Tec, corrosion prevention, bioplastics, joint ventures, net sales, net income, operating expenses, dividends, financial results